MedTrace Logo

Study on Diagnosis Value of mNGS Technology Among Diabetic Patients With Pulmonary Infections

NCT05552872 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-09-23

No results posted yet for this study

Summary

Focusing on patients with diabetes complicated with pulmonary infection, the purpose of this study is: 1) to identify the epidemiology, etiologic spectrum and status of diagnosis and treatment; 2) to explore the lower respiratory microenvironment and host immune response and then make an application in clinic.

Conditions

Interventions

DIAGNOSTIC_TEST

mNGS, IDSeq UltraTM

pathogen detection

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Jieming Qu, Ph.D., M.D. · China, Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-12-01
Completion
2025-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05552872 on ClinicalTrials.gov